EP3468603
GM-CSF tilbrigði og aðferðir til notkunar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.6.2017EP published:
13.4.2022EP application number:
17810920.3
EP translation filed:
3.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
6.6.2037Expiry date:
6.6.2023
Title in English:
GM-CSF VARIANTS AND METHODS OF USELanguage of the patent:
English
Timeline
Today
7.6.2017EP application
13.4.2022EP Publication
3.5.2022Translation submitted
15.6.2022Registration published
6.6.2023Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
RUTKOSKI, ThomasAddress:
Springhouse, Pennsylvania 19477, US
Name:
TEPLYAKOV, AlexeyAddress:
Phoenixville, Pensylvania 19460, US
Name:
WUNDERLER, NicoleAddress:
Springhouse, Pennsylvania 19477, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662347342 PDate:
8.6.2016Country:
US
Number:
201662374068 PDate:
12.8.2016Country:
US
Number:
201662423857 PDate:
18.11.2016Country:
US
Classification
Categories:
A61K 45/00, A61K 38/00, C07K 1/00, C07H 21/04, C12N 15/00, C12P 21/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 19.5.2022
Expires: 6.6.2023
Payer: Árnason Faktor ehf.